Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
KVISTGÅRD, Denmark, October 7 (ots/PRNewswire) - - 125 Patient, Prospective Randomized Placebo-Controlled Phase II Study Shows Statistically Significant Improved Overall Survival KVISTGÅRD, Denmark, October 7 /PRNewswire/ -- Bavarian Nordic has now evaluated the mature phase II data from the therapeutic prostate cancer vaccine candidate PROSTVAC(TM) ...
mehr